The Europe Biopsy Devices Market would witness market growth of 7.3% CAGR during the forecast period (2022-2028).
Biopsies are used to inspect the source of one’s symptoms or to analyse other different health circumstances. It can also determine the degree or phase of the already detected disease that has been reached. For example, the outcome of a biopsy test can demonstrate how badly an organ, such as the liver, is swollen.
It is difficult to be sure if the bump or development on the skin or a private part of the body is malignant (cancerous) or benign (non-cancerous) just by seeing or touching it but using the appropriate biopsy, the clinicians may get the appropriate insight of condition. Due to this importance of biopsy, the need for advanced biopsy devices for accurate procedures has increased.
Histopathologists observe the tissue biopsies with bare eyes to search for any noticeable irregularities and examine hand-picked parts under a complex microscope. The hand-picked parts are preserved with chemicals so that very thin slices can be cut from them. The slices are then stained to see dissimilar portions of the cells and are studied beneath a microscope to check if the tissue is irregular.
Spain is an important market for medical products, with a population of over 47 million and the fourth-largest economy in the EU. Every individual in Spain has access to advanced medical care. The majority of medical equipment and supplies in this nation are currently purchased by public healthcare facilities, which make up about 70% of the healthcare industry. These organizations involve public hospitals, health facilities, research institutions, and others.
The Germany market dominated the Europe Biopsy Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $200.5 million by 2028.The UK market is anticipated to grow at a CAGR of 6.4% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 8.1% during (2022 - 2028).
Based on Product, the market is segmented into Needle-based Biopsy Guns, Biopsy Guidance Systems, Biopsy Needles, Biopsy Forceps and Others. Based on Needle-based Biopsy Guns Type, the market is segmented into Vacuum-assisted Biopsy (VAB) Devices, Fine Needle Aspiration Biopsy (FNAB) Devices and Core Needle Biopsy (CNB) Devices. Based on Biopsy Guidance Systems Type, the market is segmented into Manual and Robotic. Based on Biopsy Needles Type, the market is segmented into Disposable and Reusable. Based on End User, the market is segmented into Hospitals, Diagnostic & Imaging Center and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Biopsy Devices Market will Hit $3 Billion by 2028, at a CAGR of 7.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Hologic, Inc., Fujifilm Holdings Corporation, B. Braun Melsungen AG, Danaher Corporation, ConMed Corporation, Becton, Dickinson and Company, Cardinal Health, Inc., Argon Medical Devices, Inc., and Cook Medical, Inc.
By Product
By End User
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 